Cite
APA Citation
Groeneveld, C. S., Fontugne, J., Cabel, L., Bernard-Pierrot, I., Radvanyi, F., Allory, Y., & de Reyniès, A. (2021). tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. European journal of cancer, 148, 181–189. http://access.bl.uk/ark:/81055/vdc_100129509526.0x00002c